Pfizer AH: 13% revenue increase
Pharmaceutical company Pfizer’s animal health division posted third-quarter 2007 revenues $636 million, a 13% increase in comparison to $562 million in the same period last year.
For the first nine months of 2007, revenues increased 12% to $1.9 billion compared to $1.7 billion in the same period last year.
Product performance
The increase in both periods is largely attributed to strong product performance in the companion animal and international livestock businesses; the acquisition of Embrex, a company with a unique vaccine delivery system that vaccinates chicks while inside their eggs; and the favorable impact of foreign exchange.
The results were made public in a company press release.
Pfizer as a total posted third-quarter 2007 revenues of $12.0 billion, a 2% decline from the same period last year.
Related websites:
Join 31,000+ subscribers
Subscribe to our newsletter to stay updated about all the need-to-know content in the poultry sector, three times a week.
